Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

Whitney CG;Farley MM;Hadler J;Harrison LH;Bennett NM;Lynfield R;Reingold A;Cieslak PR;Pilishvili T;Jackson D;Facklam RR;Jorgensen JH;Schuchat A; ;;
The New England journal of medicine 2003 Vol. 348 pp. -
408
cg2003thedecline

Abstract

The use of the pneumococcal conjugate vaccine is preventing disease in young children, for whom the vaccine is indicated, and may be reducing the rate of disease in adults. The vaccine provides an effective new tool for reducing disease caused by drug-resistant strains.

Citation

ID: 118456
Ref Key: cg2003thedecline
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
118456
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet